Peripheral Neuritis Treatment Global Market: Robust Growth Forecasted Due To Rising Prevalence Of Diabetes
The Business Research Company
Peripheral Neuritis Treatment Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034
LONDON, GREATER LONDON, UNITED KINGDOM, March 28, 2025 /EINPresswire.com/ -- Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
In recent years, the peripheral neuritis treatment market has seen significant expansion, growing from $1.84 billion in 2024 to a projected $1.93 billion in 2025, with an impressive compound annual growth rate CAGR of 5.4%. Behind this robust growth is an increase in healthcare expenditure, a rise in chronic diseases, the burgeoning burden of diseases linked to peripheral neuritis, a greater prevalence of diabetes, and an aging global population.
Just what is the future market size of the peripheral neuritis treatment industry?
Looking ahead, the peripheral neuritis treatment market is slated for considerable sustained growth. Projections indicate that it will reach $2.36 billion by 2029 at a CAGR of 5.0%. The growth in the forecast period can be ascribed to factors such as the growing number of treatment options, an increasing geriatric population, rising obesity rates, prevalence of HIV/AIDS, growth in the generic drug market, and government and healthcare initiatives. Key trends to take note of in this period include collaborations and partnerships, technological advancements, the rise in diabetic peripheral neuritis treatment product launches, increased focus on personalized medicine, development of non-pharmacological therapies and the integration of digital health tools.
Get Your Free Sample Market Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=21254&type=smp
What's driving the growth of the peripheral neuritis treatment market?
Chief among the market growth drivers is the rising incidence of diabetes. This chronic medical condition, characterized by the body's inability to properly regulate blood sugar glucose levels, is increasingly prevalent due to factors such as sedentary lifestyles, unhealthy diets, obesity, aging populations, and genetic predisposition. Peripheral neuritis treatments bolster diabetic individuals by ameliorating nerve pain, reducing inflammation, and enhancing nerve function, thereby improving their quality of life and averting complications. In fact, according to an American Diabetes Association report in November 2023, around 25.5 million people in the U.S. were diagnosed with diabetes in 2022, accounting for 7.6% of the total population. The rising prevalence of diabetes is a key driver fueling growth in the peripheral neuritis treatment market.
Order Your Report Now For A Swift Delivery: https://www.thebusinessresearchcompany.com/report/peripheral-neuritis-treatment-global-market-report
Which major companies are operating in the peripheral neuritis treatment industry?
Market leaders heavily influencing the peripheral neuritis treatment sector include Pfizer Inc., Johnson & Johnson J&J, AstraZeneca Plc, Novartis AG, GSK plc, Takeda Pharmaceuticals & Co. Ltd., Eli Lilly and Co., Mallinckrodt Pharmaceuticals plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Sun Pharmaceutical Industries Ltd., Apotex Inc., Dr Reddys Laboratories Ltd., Cipla Inc., Amneal Pharmaceuticals LLC, Lupin Ltd., Daiichi Sankyo Co. Ltd., Glenmark Pharmaceuticals Ltd., and Cadila Pharmaceuticals Ltd.
Innovation is a key trend among these industry titans. They are focusing on the development of new treatments, such as magnetic peripheral nerve stimulation mPNS to enhance nerve regeneration and reduce neuropathic pain. mPNS represents a non-invasive, neuromodulation technique utilizing magnetic fields to stimulate peripheral nerves, both managing pain and improving motor function in conditions like neuropathy and musculoskeletal disorders.
How is the peripheral neuritis treatment market segmented?
Segmentation is central to understanding the peripheral neuritis treatment market dynamics. The market is divided into:
1 Treatment Type: Pharmacological Therapies, Non Pharmacological Therapies
2 Drug Class: Anti-Depressants, Anticonvulsants, Local Anesthesia, Analgesics, Steroids, Other Drug Classes
3 Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores
4 Application: Diabetic Peripheral Neuropathy, Chemotherapy-Induced Peripheral Neuropathy, Idiopathic Peripheral Neuropathy, Other Applications
For Pharmacological Therapies, subsegments include Pain Relievers Analgesics, Antidepressants, Anticonvulsants, and Topical Medications. Non-Pharmacological Therapies are also divided further into Physical Therapy, Transcutaneous Electrical Nerve Stimulation TENS, Acupuncture, and Lifestyle And Dietary Modifications.
Where are significant regional opportunities in the peripheral neuritis treatment market?
In 2024, North America emerged as the largest regional player in the peripheral neuritis treatment market. However, the fastest-growing region during the forecast period is expected to be Asia-Pacific. The report comprehensively covers all regions including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Browse For More Similar Reports-
Neuralgia Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/neuralgia-treatment-global-market-report
Neuropathic Pain Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/neuropathic-pain-global-market-report
Neurotrophic Keratitis Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/neurotrophic-keratitis-treatment-global-market-report
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Prime yourself with the best market intelligence and stay ahead of the competition.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn
Distribution channels: Business & Economy, Companies, Healthcare & Pharmaceuticals Industry, International Organizations, World & Regional
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Submit your press release